|
|
AT A GLANCEGlossary |
|
|
Introduction |
|
|
Welcome to the UCSF AGRC course in Geriatrics and Gerontology |
|
|
Course Topics |
|
|
Overall Course Goals |
|
|
Philosophy |
|
|
Faculty |
|
|
Why Take This Course? |
|
|
The Multifaceted Face of Aging: 3 Cases |
|
|
Discussion of the Three Preceding Cases |
|
|
How To Use This Course |
|
|
Where To Start? |
|
|
Then What? |
|
|
How to Start--Case 1 |
|
|
How to Start--Case 2 |
|
|
Reflection on Two Cases |
|
|
Post Test |
|
|
Demography And Epidemiology |
|
|
The Changing Face of Aging: Objectives |
|
|
Local and Regional Variations Among Older Adults in the United States |
|
|
Implications of an Aging Society for Health Care Needs and Resources |
|
|
Common Chronic Conditions Associated with Advanced Age |
|
|
Post Test |
|
|
Biology and Physiology of Aging |
|
|
Introduction and Background |
| 2.1.1 | Table of Contents |
| 2.1.2 | Module Learning Objectives |
| 2.1.3 | Personal Exercise |
| 2.1.4 | Case Background |
| 2.1.5 | Historical View of Aging |
| 2.1.6 | Successful Aging |
| 2.1.7 | What is the Truth about Aging? |
| 2.1.8 | When Pathologies are Attributed to Aging |
| 2.1.9 | Aging or Disease? |
| 2.1.10 | Understanding Age-Related Changes |
|
|
Theories of Aging |
|
|
Physiological Changes with Aging |
|
|
Pharmacologic Considerations |
|
|
Post Test |
|
|
Socio-cultural And Psychologicial… |
|
|
Module Objectives |
|
|
Social Theories of Aging |
| 3.2.1 | Modernization Theory |
| 3.2.2 | Modernization Theory (II) |
| 3.2.3 | Criticisms of Modernization Theory |
| 3.2.4 | Role Theory |
| 3.2.5 | Role Theory (II) |
| 3.2.6 | Criticisms of Role Theory |
| 3.2.7 | Disengagement Theory |
| 3.2.8 | Activity Theory |
| 3.2.9 | Reflections (III) |
|
|
Psychological Development In Late Life |
|
|
Ethno-Cultural Issues And Age-Stratified Societies |
|
|
Late-Life Transitions |
| 3.5.1 | Normative Transitions in Later Life |
| 3.5.2 | "Off Time" Transitions |
| 3.5.3 | Reflections (VII) |
|
|
Dependent Elders: Special Concerns |
| 3.6.1 | Adult Guardianship in Euro-American Societies |
| 3.6.2 | Elder Abuse |
| 3.6.3 | Caregiving: Informal |
| 3.6.4 | Caregiving: Formal |
| 3.6.5 | Residential Care |
| 3.6.6 | Ageism and Therapeutic Nihilism |
|
|
Cultural Views of Death |
| 3.7.1 | Funeral Rites |
| 3.7.2 | The "Good Death" |
| 3.7.3 | End of Life Care |
|
|
References |
|
|
Post Test |
|
|
Assessment Of The Geriatric… |
|
|
Module Objectives |
|
|
Domains of Assessment: Functional Assessment |
|
|
Domains Of Assessment: Psychosocial Health And Functioning |
| 4.3.1 | Informal Caregiving Support Network |
| 4.3.2 | Abuse and Neglect |
| 4.3.3 | Social Support |
| 4.3.4 | Spiritual and Cultural Assessment |
| 4.3.5 | Home Assessment |
|
|
Special Considerations In Assessment |
|
|
Post Test |
|
|
Health Care Policies |
|
|
Module Objectives |
|
|
The Policy-Making Process |
|
|
Financing Health & Long Term Care |
|
|
Quality Of Care Issues In Long Term Care |
|
|
Need And Access Across The Spectrum Of Care |
|
|
References |
|
|
Post Test |
|
|
Exploring Age-Related Body… |
|
|
Cardiovascular System |
| 6.1.1 | Case 1 |
| 6.1.2 | Case 2 |
| 6.1.3 | The Cardiovascular System |
| 6.1.4 | Can These Changes Be Modified? |
| 6.1.5 | Sodium and Activity |
| 6.1.6 | Atherosclerosis |
| 6.1.7 | What Can We Do About The Process? |
| 6.1.8 | Links to Theories of Aging |
| 6.1.9 | Myocardium |
| 6.1.10 | Clinical Implications |
| 6.1.11 | Cellular Calcium |
| 6.1.12 | Functional Changes |
| 6.1.13 | Pulse Wave Velocity |
| 6.1.14 | Additional Functional Changes |
| 6.1.15 | Clinical Significance |
| 6.1.16 | Response to Stress |
| 6.1.17 | Congestive Heart Failure |
| 6.1.18 | Diastolic Versus Systolic Heart Failure |
| 6.1.19 | Case 3 |
| 6.1.20 | Case 3: Points To Consider |
| 6.1.21 | References |
| 6.1.22 | Review Question 1 |
| 6.1.23 | Review Question 2 |
|
|
Endocrine System |
| 6.2.1 | Case 1: Mr. Jones |
| 6.2.2 | Circadian Rhythms |
| 6.2.3 | Hypothalamic-Pituitary and Hypothalamic-Pituitary-Adrenal Axis |
| 6.2.4 | Growth Hormone |
| 6.2.5 | Why Does Growth Hormone Decrease? |
| 6.2.6 | Why is Growth Hormone Important to Our Clinical Practice? |
| 6.2.7 | Is This Good Clinical Practice? |
| 6.2.8 | Case 2: Discussion |
| 6.2.9 | CRH, Adrenocorticotropic Hormone/Corticotropin (ACTH), and Cortisol |
| 6.2.10 | Aging, the Stress Response, Cortisol, and Cognitive Function |
| 6.2.11 | Aldosterone |
| 6.2.12 | Dehydroepiandrosterone (DHEA) |
| 6.2.13 | The Adrenal Medulla |
| 6.2.14 | Hypothalamic-Pituitary-Thyroid Axis |
| 6.2.15 | Posterior Pituitary |
| 6.2.16 | Case 3: Clinical |
| 6.2.17 | Endocrine Pancreas |
| 6.2.18 | What Causes These Changes? |
| 6.2.19 | Can These Changes Be Prevented? |
| 6.2.20 | What Do We See Clinically? |
| 6.2.21 | Discussion Point |
| 6.2.22 | Should Age-Related Changes in Carbohydrate Metabolism Be Treated? |
| 6.2.23 | Summary Case and Evaluation Questions |
| 6.2.24 | References |
| 6.2.25 | Review Question 1 |
| 6.2.26 | Review Question 2 |
|
|
Immune System |
| 6.3.1 | Setting the Stage |
| 6.3.2 | Setting the Stage 2 |
| 6.3.3 | Overview and Background |
| 6.3.4 | What Happens with Age? |
| 6.3.5 | Non-Specific Immunity |
| 6.3.6 | The Physical Barriers |
| 6.3.7 | Acid Contents of the Stomach |
| 6.3.8 | Phagocytosis |
| 6.3.9 | The Macrophage |
| 6.3.10 | The "Natural Killer" and the "LAK" |
| 6.3.11 | Non-Specific Summary |
| 6.3.12 | Specific Immunity |
| 6.3.13 | What Happens to Specific Immunity With Age? |
| 6.3.14 | The Immune Response |
| 6.3.15 | References |
|
|
Musculo-Skeletal System |
| 6.4.1 | Case 1 |
| 6.4.2 | Case 1 Continued |
| 6.4.3 | The Inter-Relationship of the Muscle and Skeletal System |
| 6.4.4 | Muscle Changes and Function with Age |
| 6.4.5 | Changes in Muscle with Age |
| 6.4.6 | Muscle Fibers |
| 6.4.7 | What Are The Physiologic Processes That Cause These Changes? |
| 6.4.8 | What Is The Impact Of These Changes On Function? |
| 6.4.9 | Mobility Changes |
| 6.4.10 | Interventions to Minimize Changes |
| 6.4.11 | Discussion Point |
| 6.4.12 | Joints, Tendons, and Ligaments |
| 6.4.13 | Differences in Cartilage Between Aging and Osteoarthritis |
| 6.4.14 | Skeletal Changes With Age |
| 6.4.15 | Bone Components |
| 6.4.16 | Many Factors Influence Bone Health |
| 6.4.17 | Bone Loss |
| 6.4.18 | General Changes in the Bone with Age |
| 6.4.19 | Factors Influencing Whether a Fracture Will Or Will Not Occur |
| 6.4.20 | Summary Case |
| 6.4.21 | References |
|
|
Neurological System |
|
|
Renal System |
|
|
Post Test |
Module 6: Exploring Age-Related Body Systems Changes6.2: Endocrine System6.2.12: Dehydroepiandrosterone (DHEA)Dehydroepiandrosterone, or more simply, DHEA, is another steroid produced by the adrenal glands that is getting a great deal of attention from individuals interested in aging. DHEA is formed in the process of producing the various adrenal steroid hormones. There are really three forms: unconjugated; sulphated (DHEA-S), which is the most common form in the blood and is often the one that is measured; and lipoidal, about which much less is known. Hornsby (1997) notes that the human pattern of DHEA(S) biosynthesis is a fairly recent evolutionary development rather than something inherited from ancestors for whom it had a function and is no longer needed. This suggests that DHEA(S) has an important function in adults, especially after the start of puberty. Levels of DHEA are noted to decrease significantly with age (de Bruin, Vieira, et al., 2002; Ferrari, Casarotti, et al., 2001; Timiras, 2003) although there may be differences between men and women (Tilvis, R.S., Kähönen, & Härkönen, 1999). The response to ACTH is also decreased (Giordano, Di Vito et al., 2001). These changes are believed to be due to a blockage in the synthetic pathway of the hormone - that is, a primary failure in hormone synthesis—possibly related to changes in the zona reticularis of the gland (Giordano, Di Vito et al., 2001), although this remains to be proven. Of clinical importance, many biological effects have been attributed to DHEA, including improved memory, increased lean body mass, enhanced immuno-competence, and increased longevity. DHEA’s influence on longevity is thought to be through an effect on glucose 6-phosphate dehydrogenase activity and subsequently on NADPH stimulated lipogenesis. However, data are conflicting and there are concerns about its long term effects. Studies have suggested that DHEA did not benefit persons with physiological, age-related declines, that levels are not correlated with cognition or well-being, and that treatment had no effect on bone health in men (Allolio & Arlt, 2003; Kahn & Halloran, 2002; van Niekerk, Huppert et al., 2001; Moffat, Zonderman, et al., 2000). In contrast, other studies have identified positive effects on bone as well as other parameters of well-being (Labrie, Luu-The, et al., 2001; Baulieu, Thomas, et al., 2000). While animal studies have been done, sometimes with positive outcomes, data suggest some animals may not be appropriate models. For example, rodents do not synthesize DHEA(S) in the adrenal glands and do not maintain high plasma levels of DHEAS when given large doses of DHEA (Hornsby, 1997). Miller (1997) even noted in this regard that “those of us who work in animal models need to remain watchful for exceptions to our tacit assumption that mice are simply small nocturnal people with prominent whiskers” (p.1402). Because of its purported effects, DHEA is now a popular nutritional supplement. However, it can have significant side effects because it is a steroid—for example, it can be converted to potent androgens and estrogens and has been linked to hirsutism, acne, and menstrual irregularities among other things (Svec, 1997). Long term effects on the occurrence of cancer are currently not know. Svec (1997), among others, cautions about over the counter use noting that while the usual dose is about 50-100mg/day the purity of the supplements is not clear and DHEA can increase hepatic size, change hepatic texture, and change hepatic chemistry. Given the range of its effects and its potential to promote hormone sensitive cancers, it is important to ask whether an older adult is using a DHEA supplement, and to continue to evaluate subsequent studies for further information on the pros and cons of its use. |
